Loading live market data…

Halozyme Therapeutics, Inc.

NASDAQ:HALO

$75.87 USD

$0.82 (1.09%)

Volume
389.27K
Average Volume
1.81M
Market Capitalization
$9B
P/E Ratio
25.98
Dividend Yield
0.00%
Price Target
$91.50
Year High
$82.26
Year Low
$55.64
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.76

HALO Estimated and Actual Revenue by Quarter

HALO Estimated and Actual EPS by Quarter

HALO Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 2 276.75M 295.79M 285.83M 242.74M 259.44M 250.71M
2027-09-30 2 258.94M 276.76M 267.44M 227.12M 242.75M 234.57M
2027-06-30 2 255.3M 272.87M 263.68M 223.92M 239.33M 231.28M
2027-03-31 2 238.32M 254.72M 246.15M 209.03M 223.42M 215.9M
2026-12-31 2 272.91M 291.69M 281.87M 239.37M 255.85M 247.23M
2026-09-30 5 242.67M 251.05M 247.74M 212.84M 220.2M 217.29M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 2 308.63M 336.52M 321.93M 83.24M 88.97M 85.97M
2027-09-30 2 299.8M 326.88M 312.72M 77.88M 83.24M 80.44M
2027-06-30 2 292.73M 319.18M 305.34M 76.79M 82.07M 79.31M
2027-03-31 2 266.22M 290.28M 277.7M 71.68M 76.61M 74.03M
2026-12-31 2 300.62M 327.78M 313.58M 82.08M 87.73M 84.78M
2026-09-30 5 255.12M 281.29M 268.2M 72.99M 75.51M 74.51M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 2 519.38M 555.12M 536.43M 2 2.51174 2.73868 2.62
2027-09-30 2 485.95M 519.4M 501.91M 1 2.43984 2.66028 2.545
2027-06-30 2 479.12M 512.09M 494.85M 1 2.38232 2.59756 2.485
2027-03-31 2 447.26M 478.04M 461.94M 2 2.16662 2.36237 2.26
2026-12-31 2 512.18M 547.42M 528.99M 2 2.44657 2.66762 2.55202
2026-09-30 5 455.41M 471.15M 464.93M 4 2.07626 2.2892 2.18273